Transplantation Proceedings
Volume 39, Issue 6 , Pages 1847-1850 , July 2007

Topical Photodynamic Therapy of Actinic Keratosis in Renal Transplant Recipients

  • S. Piaserico

      Affiliations

    • Clinica Dermatologica, Azienda Ospedale-Università di Padova, Istituto Oncologico Veneto, Padova, Italy
    • Istituto Oncologico Veneto, Azienda Ospedale-Università di Padova, Istituto Oncologico Veneto, Padova, Italy.
    • Corresponding Author InformationAddress reprint requests to Stefano Piaserico, MD, Unit of Dermatology, Department of Medical and Surgical Sciences, University of Padova, Via Cesare Battisti, 206, 35128 Padova, Italy.
    • ,
  • A. Belloni Fortina

      Affiliations

    • Dipartimento di Pediatria, Azienda Ospedale-Università di Padova, Istituto Oncologico Veneto, Padova, Italy
    • ,
  • P. Rigotti

      Affiliations

    • Clinica Chirurgica III, Azienda Ospedale-Università di Padova, Istituto Oncologico Veneto, Padova, Italy
    • ,
  • B. Rossi

      Affiliations

    • Clinica Chirurgica III, Azienda Ospedale-Università di Padova, Istituto Oncologico Veneto, Padova, Italy
    • ,
  • N. Baldan

      Affiliations

    • Clinica Chirurgica III, Azienda Ospedale-Università di Padova, Istituto Oncologico Veneto, Padova, Italy
    • ,
  • M. Alaibac

      Affiliations

    • Clinica Dermatologica, Azienda Ospedale-Università di Padova, Istituto Oncologico Veneto, Padova, Italy
    • ,
  • F. Marchini

      Affiliations

    • U.O. Nefrologia, Azienda Ospedale-Università di Padova, Istituto Oncologico Veneto, Padova, Italy

References 

  1. Euvrard S, Kanitakis J, Claudy A. Skin cancers after organ transplantation. N Engl J Med. 2003;348:1681
  2. Berg D, Otley CC. Skin cancer in organ transplant recipients: epidemiology, pathogenesis, and management. J Am Acad Dermatol. 2002;47:1
  3. Bouwes Bavinck JN, Hardie DR, Green A, et al. The risk of skin cancer in renal transplant recipients in Queensland, Australia (A follow-up study). Transplantation. 1996;61:715
  4. Fuente MJ, Sabat M, Roca J, et al. Br J Dermatol. 2003;149:1221
  5. Belloni Fortina A, Piaserico S, Caforio ALP, et al. Immunosuppressive level and other risk factors for basal cell carcinoma and squamous cell carcinoma in heart transplant recipients. Arch Dermatol. 2004;140:1079
  6. Belloni Fortina A, Caforio ALP, Piaserico S, et al. Skin cancer in heart transplant recipients: frequency and risk factor analysis. J Heart Lung Transplant. 2000;19:249
  7. Wulf HC, Pavel S, Stender I, et al. Topical photodynamic therapy for prevention of new skin lesions in renal transplant recipients. Acta Derm Venereol. 2006;86:25
  8. Dragieva G, Prinz BM, Hafner J, et al. A randomized controlled clinical trial of topical photodynamic therapy with methyl aminolevulinate in the treatment of actinic keratoses in transplant recipients. Br J Dermatol. 2004;151:196
  9. Szeimes RM, Karrer S, Radakovic-Fijan S, et al. Photodynamic therapy using topical methyl 5-aminolevulinate compared with cryotherapy for actinic keratosis: a prospective randomized study. J Am Acad Dermatol. 2002;47:258
  10. Freeman M, Vinciullo C, Francis D, et al. A comparison of photodynamic therapy using topical methyl aminolevulinate with single cycle cryotherapy in patients with actinic keratosis: a prospective, randomized study. J Dermatol Treat. 2003;14:99
  11. Morton CA, Brown SB, Collins S, et al. Guidelines for topical photodynamic therapy: report of a workshop of the British Photodermatology Group. Br J Dermatol. 2002;146:552
  12. Brown VL, Atkins CL, Ghali L, et al. Safety and efficacy of 5% imiquimod cream for the treatment of skin dysplasia in high-risk renal transplant recipients. Arch Dermatol. 2005;141:985
  13. Szeimies RM, Karrer S, Sauerwald A, et al. Photodynamic therapy with topical application if 5-aminolaevulinic acid in the treatment of actinic keratoses: an initial clinical study. Dermatology. 1996;192:246
  14. Jeffes EW, McCullough JL, Weinstein GD, et al. Photodynamic therapy of actinic keratoses with topical 5-aminolaevulinic acid. Arch Dermatol. 1997;133:727
  15. Szeimies RM, Morton CA, Sidoroff A, et al. Photodynamic therapy for non-melanoma skin cancer. Acta Derm Venereol. 2005;85:483
  16. De Graaf YGL, Kennedy C, Wolterbeek R, et al. Photodynamic therapy does not prevent cutaneous squamous-cell carcinoma in organ transplant recipients: result of a randomized-controlled trial. J Invest Dermatol. 2006;126:569
  17. Bashkatov AN, Genina EA, Kochubey VI, et al. Optical properties of human skin, subcutaneous and mucous tissues in the wavelength range from 400 to 2000 nm. J Physics. 2005;38:2543
  18. Oseroff A. PDT as a cytotoxic agent and biological response modifier: implications for cancer prevention and treatment in immunosuppressed and immunocompetent patients. J Invest Dermatol. 2006;126:542
  19. Van Duijnhoven FH, Aalbers RIJM, Rovers JP, et al. The immunological consequences of photodynamic treatment of cancer, a literature review. Immunobiol. 2003;207:105

PII: S0041-1345(07)00619-7

doi: 10.1016/j.transproceed.2007.05.040

Transplantation Proceedings
Volume 39, Issue 6 , Pages 1847-1850 , July 2007

Article Tools

* Image Usage & Resolution